Real gains but practical limitations to glycaemic control with insulin in type 2 diabetes
Background. Insulin is increasingly used for type 2 diabetes when oral therapy is inadequate. We have examined the results in unselected patients in a UK hospital diabetes clinic. Methods. Clinical database records from 1994 to 2002 were analysed for anthropomorphic data, blood pressure, HbA1C and p...
Autori principali: | Gardner, S, Dunachie, S, Levy, J |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
2004
|
Documenti analoghi
Documenti analoghi
-
The association between hypomagnesemia and poor glycaemic control in type 1 diabetes is limited to insulin resistant individuals
di: Lynette J. Oost, et al.
Pubblicazione: (2022-04-01) -
Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gain
di: Daniela Riebenfeld, et al.
Pubblicazione: (2015-02-01) -
Glycaemic control and cardiovascular risk in insulin-treated patients with type 2 diabetes in Germany and the UK
di: Gough, S, et al.
Pubblicazione: (2008) -
Comparison of Coagulation Profile in Type 2 Diabetic Patients with Good Glycaemic Control and Poor Glycaemic Control
di: Binia Sherin, et al.
Pubblicazione: (2020-07-01) -
Study on glycaemic control by canagliflozin and its effect on insulin resistance and plasma ketone in type 2 diabetes mellitus patients
di: J S Kumar, et al.
Pubblicazione: (2019-01-01)